About Dr Ameet Dhar
Consultant Gastroenterologist and Hepatologist
Digestive Health
Sub-specialties: Hepatology, Gastroenterology, Liver, Gastroscopy, Colonoscopy, Flexible Sigmoidoscopy, Abdominal Pain, Liver Disease, Liver Cirrhosis , Fatty Liver Disease, Alcoholic Liver Disease, Abnormal Liver Function, Liver Biopsy, Fibroscan, Drainage of Ascites, Autoimmune Liver Disease, Drug Induced Liver Disease, Jaundice.
Dr Ameet Dhar is a leading Consultant Gastroenterologist and Hepatologist at OneWelbeck Digestive Health, Clinical Lead for Hepatology at Imperial College Healthcare NHS Trust, and Lead for the Hepatology Clinical Reference Group for North West London NHS.
Bookings: Tel: 
Dr Ameet Dhar is a leading Consultant Gastroenterologist and Hepatologist at OneWelbeck Digestive Health, Clinical Lead for Hepatology at Imperial College Healthcare NHS Trust, and Lead for the Hepatology Clinical Reference Group for North West London NHS.
Areas of Expertise
Dr Ameet Dhar performs a range of investigations including:
- Gastroscopy
- Colonoscopy
- Flexible sigmoidoscopy
- Liver biopsy
- Fibroscan
- Drainage of ascites
Some of the symptoms and conditions he commonly investigates, and treats are:
- Abdominal pain
- Diagnosis and assessment of liver disease and cirrhosis
- Fatty liver
- Alcohol related liver disease
- Abnormal liver function
- Autoimmune liver disease
- Drug induced liver disease
- Jaundice
About Dr Ameet Dhar
Dr Ameet Dhar is a Consultant Gastroenterologist and Hepatologist at OneWelbeck Digestive Health and has specialist expertise in endoscopy and general hepatology, liver cirrhosis and liver failure, portal hypertension, vascular disorders of the liver and pre and post liver transplantation medicine.
Dr Dhar holds clinical posts as a Consultant Hepatologist and Head of Service at Imperial College Healthcare NHS Trust and in the Department of Hepatology and Liver Transplantation at Royal Free Hospital, London as well as being the lead for cirrhosis and portal hypertension, liver pre-transplant and post-transplant care at Imperial College Healthcare. Additionally, he is an honorary senior lecturer at Imperial College with research interests including aspects of care for patients with cirrhosis and interventions to prevent liver fibrosis and improving survival. He has co-authored a multitude of peer-review publications and regularly presents at both national and international conferences.
Dr Ameet Dhar, qualified in medicine from Guy’s and St. Thomas’s Hospitals, London. He completed his training in general internal medicine and gastroenterology at North West London, with sub-specialty accreditation in hepatology from Imperial College Healthcare NHS Trust and Royal Free Hospital, during which he also obtained his PhD for research into the mechanisms of liver fibrosis, and the role of coagulation proteins.
Additional Information
Qualifications
- BSc
- MBBS
- MRCP
- PhD
- FRCP
Awards
- Clinical excellence awards (NHS)
- Memberships
- Fellow Royal College Physicians
- European Association of the Study of the Liver (EASL)
- British Association of the Study of the Liver (BASL)
Research Highlights
Dr Dhar is active in research and regularly publishes and presents his work nationally and internationally. Selected recent publications include:
- Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections. March 2021. Frontline Gastroenterology
- Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis. February 2021. Journal of Hepatology
- Liver disease and COVID‐19—not the perfect storm. August 2020. Alimentary Pharmacology & Therapeutics
- A Review of Liver Fibrosis and Emerging Therapies. December 2019. European Medical Journal
- Current and future pharmacological therapies for managing cirrhosis and its complications. Feb 2019. World Journal of Gastroenterology
- Thrombin and factor Xa link the coagulation system with liver fibrosis. May 2018. BMC Gastroenterology
- Grand Round: Anticoagulation in Chronic Liver Disease. January 2017. Journal of hepatology